Lilly recruits Avidity Biosciences to develop antibody-oligonucleotide conjugates

Monday, April 22, 2019 - 05:44 in Biology & Nature

Avidity's technology will help the duo get RNA therapies to immune cells

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net